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Respiratory syncytial virus (RSV) is an impor-
tant human respiratory pathogen (Borchers 
et al., 2013). Infection with RSV manifests as 
a simple common cold in the majority of cases. 
However, in 2–3% of young children it leads 
to severe bronchiolitis and viral pneumonia, 
and it remains the major cause of infant hospi-
talization in the developed world. The varia-
tion in disease severity is caused by both host 
and viral factors and has previously been linked 
to polymorphisms in several innate immunity 
genes, including many that control the IFN 
system (Tal et al., 2004; Awomoyi et al., 2007; 
Janssen et al., 2007; Tulic et al., 2007; Siezen 
et al., 2009). IFNs may therefore be key regu-
lators of RSV-induced lung inflammation, but 
it remains unclear which cell types and molec-
ular pathways mediate IFN production in re-
sponse to RSV infection and how IFNs then 
impact airway inflammation and bronchiolitis.
Type I IFNs, and the related group of type 
III IFNs, serve as a major innate immune bar-
rier to viral infection. They can be produced 
rapidly by infected cells in response to viral in-
vasion through engagement of cytosolic recep-
tors that detect the presence of viral genomes 
or products of viral replication in the cytosol. 
In the case of RNA viruses such as RSV, 
the retinoic acid–inducible gene 1 (RIG-I)–like 
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Type I interferons (IFNs) are important for host defense from viral infections, acting to 
restrict viral production in infected cells and to promote antiviral immune responses. How-
ever, the type I IFN system has also been associated with severe lung inflammatory disease 
in response to respiratory syncytial virus (RSV). Which cells produce type I IFNs upon RSV 
infection and how this directs immune responses to the virus, and potentially results in 
pathological inflammation, is unclear. Here, we show that alveolar macrophages (AMs) are 
the major source of type I IFNs upon RSV infection in mice. AMs detect RSV via mitochon-
drial antiviral signaling protein (MAVS)–coupled retinoic acid–inducible gene  (RIG-I)–like 
receptors (RLRs), and loss of MAVS greatly compromises innate immune restriction of RSV. 
This is largely attributable to loss of type I IFN–dependent induction of monocyte chemo-
attractants and subsequent reduced recruitment of inflammatory monocytes (infMo) to the 
lungs. Notably, the latter have potent antiviral activity and are essential to control infection 
and lessen disease severity. Thus, infMo recruitment constitutes an important and hitherto 
underappreciated, cell-extrinsic mechanism of type I IFN–mediated antiviral activity. 
Dysregulation of this system of host antiviral defense may underlie the development of 
RSV-induced severe lung inflammation.
© 2015 Goritzka et al. This article is distributed under the terms of an Attribution– 
Noncommercial–Share Alike–No Mirror Sites license for the first six months 
after the publication date (see http://www.rupress.org/terms). After six months 
it is available under a Creative Commons License (Attribution–Noncommercial– 
Share Alike 3.0 Unported license, as described at http://creativecommons.org/ 
licenses/by-nc-sa/3.0/).
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to produce type I IFNs after virus exposure in vitro (Jewell 
et al., 2007; Bhoj et al., 2008; Demoor et al., 2012; Schijf et al., 
2013). Lung epithelial cells and pDCs have additionally been 
suggested to produce type I IFNs during experimental RSV 
infection in mice (Smit et al., 2006; Jewell et al., 2007). 
However, type I IFNs are notoriously difficult to detect 
in vivo as they are made only transiently. Thus, despite the 
genetic association between the type I IFN system and RSV 
disease, the cellular source of type I IFNs and the pathways 
leading to type I IFN production during RSV infection 
in vivo have not been truly elucidated.
Irrespective of source, all type I IFN species bind a sin-
gle IFN-/ receptor (IFNAR) expressed on all nucleated 
cells that signals through a JAK–STAT pathway to induce 
more than 300 IFN-stimulated genes (ISGs). These include 
components of the viral detection pathway themselves (e.g., 
RLRs), resulting in a positive feedback loop of virus-driven 
IFN production. ISGs also include a plethora of other genes 
whose products limit virus replication. For example, 2-5 
oligoadenylate synthase 1 (OAS1), IFN-induced transmem-
brane protein 3 (IFITM3), or cyclic GMP-AMP synthase 
(cGAS) have all been shown to interfere with RSV replication 
receptors (RLRs), RIG-I and melanoma differentiation– 
associated protein 5 (MDA5), sense atypical RNA species as-
sociated with viral infection (Liu et al., 2007; Loo et al., 2008; 
Yoboua et al., 2010; Goubau et al., 2013). Activated RLRs 
then signal through the adaptor, mitochondrial antiviral sig-
naling protein (MAVS), to induce activation of transcription 
factors belonging to the nuclear NF-B and IFN regulatory 
factor (IRF) families, which coordinately act to induce the 
transcription of type I and III IFN genes. Type I IFNs can 
also be produced via an RLR-independent manner by cells 
that detect the extracellular presence of virions or virus- 
infected cells. In such cases, members of the TLR family are 
often involved and RSV has been shown to trigger TLR2, 
TLR3, TLR4, and TLR7/8 (Marr et al., 2013).
Consistent with the fact that all cell types can be infected 
by viruses, every nucleated cell expresses RLRs and can pro-
duce type I IFNs via the cytosolic detection pathway. In con-
trast, the extracellular virus detection pathway via TLRs 
is predominantly active in immune cells, including macro-
phages and DCs, especially plasmacytoid DCs (pDCs). In the 
case of RSV, epithelial cells, fibroblasts, pDCs, alveolar mac-
rophages (AMs), and conventional DCs have all been shown 
Figure . GFP+ AMs in RSV-infected Ifna6gfp/+ 
mice. (A) Percentage and number of GFP+ pulmo-
nary leukocytes in RSV-infected Ifna6gfp/+ mice over 
time. 0 h represents mock (PBS)-infected mice. Data 
are mean ± SEM of five mice per group and repre-
sentative of at least three independent experiments. 
(B) Representative flow cytometry plots of GFP  
expression in pDCs (CD11cintCD11bloB220hiSiglec-
HhiLy6Chi), epithelial cells (CD45loEpCAMhiCD31lo), 
CD11b+ DCs (CD11chiCD11bhiCD64loLy6Clo), CD103+ 
DCs (CD11chiCD11bloCD103hi), CD64+ inflammatory 
cells (CD11bhiCD64hi), eosinophils (CD11cloSiglec-Fhi), 
neutrophils (CD11bhiLy6Ghi), and endothelial cells 
(CD45loEpCAMloCD31hi) from Ifna6gfp/+ mice at 18 h 
p.i. (C) Representative plots of GFP expression in 
Siglec-FhiCD11chi AMs from Ifna6gfp/+ mice 18 h 
after mock (PBS) or RSV infection. In B and C, the 
data represent at least three independent experi-
ments with five mice per experiment. (D) Percentage 
and total number of GFP+ AMs in the lungs 18 h 
after mock (PBS) or RSV infection. Each dot repre-
sents one mouse. Data are pooled from two inde-
pendent experiments representing at least six 
experiments, and mean ± SEM of 10 mice is depicted. 
(A and D) Statistical significance of differences  
between mock (0 h)- and RSV-infected mice at different 
time points (A) and between mock (PBS)- and RSV-
infected mice at 18 h p.i. (D) was determined by 
unpaired Student’s t test. **, P < 0.01; ***, P < 0.001.
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We assessed the presence of GFP signal in different lung 
cell types at 18 h p.i. by flow cytometry using the gating 
strategy shown in Fig. S1 (A and B). Although pDCs and epi-
thelial cells are reported to be the main type I IFN producers 
during RSV infection (Smit et al., 2006; Jewell et al., 2007; 
Schijf et al., 2013), no GFP signal was detectable in either cell 
type (Fig. 1 B). Furthermore, there was no GFP expression in 
CD11b+ DCs, CD103+ DCs, CD64hi inflammatory cells, eo-
sinophils, neutrophils, or endothelial cells (Fig. 1 B). In con-
trast, around 7% of AMs displayed a detectable GFP signal 
(Fig. 1, C and D). Analysis at different time points confirmed 
the presence of GFP signal exclusively among AMs (Fig. 1, 
C and D; and not depicted). Of note, AMs up-regulated CD11b, 
a marker not normally expressed on that cell type, during the 
course of infection and GFP+ AMs were all CD11bhi after 
day 2 p.i. (not depicted).
To independently validate these findings and measure ad-
ditional type I IFN species, CD45 and CD45+ cells from 
naive or infected lungs from C57BL/6 mice were purified by 
cell sorting, and the levels of Ifna5 and Ifnb mRNA were de-
termined by quantitative RT-PCR (Fig. 2 A; for gating see 
Fig. S1 B). Concordant with the earlier results in Fig. 1, 
CD45 stromal cells expressed limited amounts of Ifna5 and 
Ifnb when compared with CD45+ cells (Fig. 2 A). To distin-
guish among the latter, different lung leukocyte cell popula-
tions were purified by cell sorting from infected Ifna6gfp/+ 
mice (for gating strategy see Fig. S1, A and B). As expected, 
GFP+ AMs contained the highest levels of Ifna5 and Ifnb tran-
scripts (Fig. 2 B). Low levels could also be detected in GFP 
AMs and pDCs, arguing for slight underreporting in Ifna6gfp/+ 
mice. In conclusion, AMs account for the majority of type I 
IFN production in the lungs of RSV-infected mice with only 
a minor contribution from pDCs.
Type I IFN production by AMs in response  
to RSV infection is RLR–MAVS dependent
Next we dissected the pathway leading to type I IFN induc-
tion by lung AMs. Live virus was necessary as UV-inactivated 
RSV administered i.n. did not elicit GFP expression (Fig. 3 A). 
Importantly, live virus failed to induce a GFP signal in AMs 
from Ifna6gfp/+ mice deficient in the RLR adaptor protein 
MAVS (Ifna6gfp/+ Mavs/ mice; Fig. 3 A). This was true at 
all time points examined, from 8 to 96 h p.i. (Fig. 3 B), dem-
onstrating a key role for the RLR pathway in the AM re-
sponse to RSV. Consistent with that notion, primary AMs 
isolated from Ifna6gfp/+ mice but not from Ifna6gfp/+ Mavs/ 
mice secreted large amounts of IFN- in response to increas-
ing doses of RSV ex vivo (Fig. 3 C). The lack of IFN- pro-
duction by Ifna6gfp/+ Mavs/ AMs was maintained even when 
the cells were stimulated with RSV up to multiplicities of 
infection (MOIs) of 20 (not depicted).
A previous study using Newcastle disease virus showed 
that loss of IFN- production in Mavs/ AMs leads to com-
pensatory IFN- secretion by pDCs (Kumagai et al., 2007). 
In contrast, no compensatory GFP+ lung cell population was 
detectable at any time point (8 h to 9 d p.i.) in RSV-infected 
and limit productive infection (Behera et al., 2002; Everitt 
et al., 2013; Goubau et al., 2013; Schoggins et al., 2014). The 
cell-intrinsic control of viral replication by ISG products is 
thought to be a major component of the antiviral state con-
ferred by type I IFN exposure and to underlie the ability of 
IFNs to protect healthy cells from viral infection (Goubau 
et al., 2013).
Our group recently found that, in addition to acting to 
limit viral infection, IFNAR signaling is also critical for induc-
ing lung inflammation in response to RSV infection in mice 
(Goritzka et al., 2014). In the absence of IFNAR, proin-
flammatory cytokines and chemokines were not produced in 
RSV-infected lungs (Goritzka et al., 2014). This observation 
suggested that type I IFNs act in lung innate immunity beyond 
promoting cell-intrinsic viral control, by inducing inflamma-
tion. Type I IFN–driven lung inflammation could be a by-
stander phenomenon or a cell-extrinsic means of controlling 
virus infection through the recruitment of antiviral inflam-
matory cells. Here, we address which lung cell populations 
produce type I IFNs during RSV infection in vivo and how 
this translates into viral control. We show that the MAVS- 
dependent RLR pathway in AMs accounts for almost all type I 
IFN production in the lungs of RSV-infected mice. MAVS-
dependent type I IFN production by AMs induces local 
production of monocyte chemoattractants and leads to the 
recruitment of inflammatory monocyte (infMo)–derived cells 
to the lung. Notably, the recruited cells have potent and non-
redundant antiviral effects, which are essential to limit lung 
viral load and decrease disease severity. Our work indicates an 
underappreciated monocyte-dependent cell-extrinsic mech-
anism underlying the antiviral action of type I IFNs and high-
lights the importance of balanced lung inflammation in early 
antiviral defense. Dysregulation of type I IFN–mediated inflam-
mation might offset its beneficial function and underlie the 
development of severe RSV disease.
RESULTS
Identification of pulmonary cell populations  
producing type I IFNs in response to RSV
Type I IFNs are produced transiently after viral infection, and 
the identification of IFN-producing cells in vivo can be 
problematic. To identify type I IFN–producing cells in the 
lungs of mice infected with RSV, we used Ifna6gfp/+ mice, a 
transgenic model in which GFP is expressed under the con-
trol of the Ifna6 promoter (Kumagai et al., 2007). Mice were 
i.n. infected with 2 × 106 focus-forming units (FFU) of RSV 
and followed over time. First, we monitored the level of GFP 
expression. GFP signal was first detectable at 8 h in CD45+ 
leukocytes but not in CD45 cells (Fig. 1 A and not depicted). 
The percentage and number of GFP+ leukocytes increased 
steadily from 8 to 18 h postinfection (p.i.) and declined there-
after (Fig. 1 A). Thus, Ifna6gfp/+ mice appear to be a valid model 
for monitoring type I IFN expression in the lung after RSV 
challenge. The persistence of the GFP signal increases the like-
lihood of detecting relevant type I IFN–producing cells dur-
ing the course of infection.
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Mavs/ mice compared with MAVS-sufficient controls 
(Fig. 4 B). The bulk of the early inflammatory response to 
RSV infection was also strongly dependent on MAVS as tran-
scripts encoding proinflammatory cytokines (e.g., TNF, IL-6, 
and IL-1) were largely undetectable in lungs of Mavs/ mice 
while being highly induced in control mice (Fig. 4 C; Bhoj 
et al., 2008). This is likely a secondary effect of the loss of 
type I IFNs as we have observed a similar phenotype in 
IFNAR1-deficient mice (Goritzka et al., 2014).
We further determined the effect of RSV infection on 
inflammatory cell recruitment to the lungs and extravasation 
into the airways. The recruitment of polymorphonuclear 
phagocytes, which occurs early after infection, was largely 
independent of MAVS as similar proportions and numbers of 
neutrophils were present in bronchoalveolar lavages (BALs; 
a representation of the airways) and lung cell suspensions from 
infected MAVS-sufficient and -deficient mice (Fig. 4, D and E). 
Consistent with this notion, substantial expression of the 
neutrophil chemoattractant Cxcl1 was detected early after in-
fection in both WT and Mavs/ mice even though levels 
were higher in the former group (Fig. 4 F). Similarly, Cxcl1 
induction and unimpaired neutrophil recruitment was also 
observed in IFNAR1-deficient mice infected with RSV 
(Goritzka et al., 2014). The recruitment of T cells, including 
RSV-specific CD8+ T cells, detected at day 8 p.i., also did 
not differ between WT and Mavs/ mice (Fig. 4, G–I; Bhoj 
et al., 2008; Demoor et al., 2012). In contrast, we noticed a 
large difference between WT and Mavs/ mice in lung ac-
cumulation of CD64hi inflammatory cells after RSV infection. 
Ifna6gfp/+ Mavs/ mice (not depicted). Furthermore, no ex-
pression of Ifna5 or Ifnb was detected in sorted AMs, CD103+ 
DCs, CD11b+ DCs, or pDCs from Ifna6gfp/+ Mavs/ mice 
18 h p.i. (not depicted). Consistent with the loss of GFP sig-
nal and the notion that AMs are the main producers of type I 
IFNs in this model, we found no type I IFNs (IFN-3 and 
IFN-) in total lung homogenates of infected Ifna6gfp/+ Mavs/ 
mice even though these cytokines were easily detected at 
18 h p.i. in MAVS-sufficient Ifna6gfp/+ controls (Fig. 3 D). 
Type III IFNs (IFN-2/3) or IFN- was also not detectable 
in the lungs of Ifna6gfp/+ Mavs/ mice (Fig. 3 E). Consistent 
with these results, induction of mRNAs encoding selected 
ISGs (Viperin, OAS-1, protein kinase R [PKR], or MX-1) 
was not observed in Ifna6gfp/+ Mavs/ mice but was detected 
shortly after infection in MAVS-sufficient Ifna6gfp/+ controls 
(Fig. 3 F). Altogether, these data suggest that type I IFN– 
dependent antiviral responses to RSV are primarily caused by 
triggering of the RLR–MAVS pathway in AMs.
MAVS controls the innate immune response to RSV
To test whether loss of the type I IFN response to RSV affects 
the outcome of infection, we determined viral load in the 
lungs of Ifna6gfp/+ (henceforth abbreviated WT) and Ifna6gfp/+ 
Mavs/ (henceforth abbreviated Mavs/) mice. In accor-
dance with previous studies by Bhoj et al. (2008) and Demoor 
et al. (2012), Mavs/ mice had higher lung viral titers than 
control mice throughout the infection period and displayed 
delayed viral clearance (Fig. 4 A). Moreover, infection with 
RSV caused greater weight loss from day 6 until day 10 p.i. in 
Figure . AMs are the main producers of type I  
IFNs in lungs of RSV-infected mice. (A) Lung cells  
from naive C57BL/6 mice or 4 and 12 h after RSV infec-
tion were sorted into CD45 and CD45+ fractions. Expres-
sion of Ifna5 and Ifnb mRNA was assessed by quantitative 
RT-PCR. One representative experiment of three is shown  
using pooled cells from five mice for each time point.  
(B) Lung leukocyte populations from Ifna6gfp/+ mice at 18 h  
after RSV infection were sorted into GFP+ and GFP AMs 
(Siglec-FhiCD11chi), CD103+ DCs (CD11chiCD11bloCD103hi), 
CD11b+ DCs (CD11chiCD11bhiCD64loLy6Clo), pDCs (CD11cint 
CD11bloB220hiSiglec-Hhi), moDCs (CD11bhiCD64hiCD11chi), 
infMos (CD11bhiCD64hiCD11clo), and neutrophils (CD11bhi 
Ly6Ghi). Expression of Ifna5 and Ifnb mRNA was assessed by 
quantitative RT-PCR. Each point depicts data from an individual 
experiment (two to three) with cells sorted from pools of 25–40 
mice per experiment. The symbols represent different cell types 
as indicated, and the horizontal bars represent the mean.
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that most of these cells expressed Ly6C at day 1 p.i., sugges-
tive of a monocytic origin. Ly6C expression was gradually 
down-regulated during the course of the infection (Fig. 5, C 
and D). Differential expression of CD11c further subdivided 
the CD64hi inflammatory cells into what has previously been 
described as moDCs (CD11chiCD11bhiCD64hi) and infMos 
(CD11cloCD11bhiCD64hi; Fig. 5, C and E). The early re-
cruited CD64hi inflammatory cells were a mix of CD11chi 
moDCs and CD11clo infMos, whereas most of the cells by 
day 2 p.i. were CD11chi moDCs (Fig. 5 E). Interestingly, 
both moDCs and infMos produced TNF (Fig. 5, F and G; 
and not depicted; Shi and Pamer, 2011). Therefore, the lack 
of detectable TNF in the lungs of Mavs/ mice infected 
In WT mice, leukocytes positive for CD64 and CD11b rep-
resented 40% of the total leukocyte population at day 2 p.i., 
but those cells were completely absent in lungs of Mavs/ 
mice at all time points (Fig. 5, A and B). Thus, MAVS defi-
ciency results in a general impairment of inflammatory cyto-
kine production and absence of CD64hi inflammatory cells in 
the lungs after RSV infection, but does not impact neutro-
phil or T cell recruitment.
infMos and monocyte-derived DCs (moDCs)  
are recruited to lungs of RSV-infected mice
Phenotypic characterization of the CD64hi inflammatory cells 
recruited to the lungs of RSV-infected WT mice showed 
Figure . Type I IFN production by AMs is dependent on MAVS. (A) GFP expression in AMs from the indicated strains of mice was assessed 18 h after 
mock (PBS), RSV, or UV-inactivated RSV (UV RSV) instillation. (B) Percentage and number of GFP+ AMs during the time course of RSV infection in Ifna6gfp/+ and 
Ifna6gfp/+ Mavs/ mice. 0 h represents mock (PBS)-infected mice. (C) Secretion of IFN- from primary AMs of the indicated genotypes after ex vivo exposure for 
20 h to medium or the indicated MOIs of RSV or UV-RSV (MOI of 5; UV 5). (D) Analysis of IFN-3 and IFN- protein levels in lung homogenates from mice of the 
indicated genotypes at the indicated times p.i. (E and F) Levels of Ifnl and Ifng (E) and Rsad2, Oas1a, Eif2ak2, and Mx1 transcripts (F) in lung tissue from mock 
(0 h)- or RSV-infected mice of the indicated genotypes at the indicated times p.i. Flow cytometry plots in A represent four to five mice per group and are repre-
sentative of at least two independent experiments. Data in B and D–F are presented as mean ± SEM of four to five mice per group and are representative of at 
least two independent experiments. Statistical significance of differences between indicated genotypes at each time point was determined by unpaired Student’s  
t test. Results in C are pooled from two independent experiments with at least three individual cultures per condition and presented as mean ± SEM. Statistical 
significance of differences between indicated groups was determined by unpaired Student’s t test. *, P < 0.05; **, P < 0.01; ***, P < 0.001; ns, not significant.
 o
n
 April 22, 2015
jem.rupress.org
D
ow
nloaded from
 
Published April 20, 2015
6 of 6 Type I IFN regulation of immunity to RSV | Goritzka et al.
AMs promote the recruitment of CD6hi cells via type I 
IFN–dependent induction of monocyte chemoattractants
As Mavs/ mice possess normal numbers of blood mono-
cytes (not depicted), the failure of CD64hi inflammatory cells 
to accumulate in lungs after infection was likely caused by 
a deficiency in recruitment. The chemoattractants CCL2, 
CCL7, and CCL12 (all ligands for CCR2) are critical for 
monocyte recruitment to inflamed tissues (Shi and Pamer, 
2011). We found that all three chemokines were induced in 
lung tissue shortly after RSV infection in WT but not in 
Mavs/ mice (Fig. 7, A and B). Type I IFNs have been im-
plicated in the induction of CCL2 (Iijima et al., 2011; Majer 
et al., 2012; Conrady et al., 2013), and consistent with that 
notion, IFNAR1-deficient mice also failed to produce and 
with RSV (Fig. 4 C) appears related to the failure to recruit 
CD64hi inflammatory cells.
To confirm these conclusions, C57BL/6 mice were 
treated with an antibody against CCR2 (anti-CCR2), which 
depletes monocytes from the circulation and therefore pre-
vents their migration into inflamed tissue (Mack et al., 2001). 
Confirming their monocytic origin, CD64hi inflammatory 
cells were absent from the lungs of RSV-infected mice that 
had been treated with anti-CCR2 (Fig. 6, A and B). This 
was accompanied by a marked decrease in detectable TNF 
transcripts in the lungs (Fig. 6 C). Thus, CD64hi inflamma-
tory cells recruited to the lungs after RSV infection are de-
rived from monocytes and are largely responsible for local 
TNF production.
Figure . MAVS regulates innate resistance 
to RSV and modulates lung inflammation.  
(A and B) Lung viral load (A) and percentage of 
original weight (B) after RSV or mock (PBS) infec-
tion of the indicated strains was determined by 
quantification of viral L gene copies in lungs of 
RSV-infected mice and weighing at the indicated 
time points. Results are presented as mean ± SEM 
of 10 mice per group. (C) Levels of Tnfa, Il6, and 
Il1b transcripts in lung tissue from the indicated 
strains were measured by quantitative RT-PCR.  
0 h represents mock (PBS)-infected mice. (D) BAL 
was obtained from mock- or RSV-infected WT or 
Mavs/ mice on day 1 p.i. The frequency of neu-
trophils was determined using differential cell 
counting of H&E-stained cytospin slides. (E) Total 
number of lung neutrophils (CD11b+Ly6G+) was 
determined by flow cytometry (see gating in  
Fig. S1 A) in WT or Mavs/ mice at different time 
points p.i. (F) Expression of Cxcl1 in lung tissue 
from WT or Mavs/ mice was measured by 
quantitative RT-PCR. (G and H) Number of CD4+ 
(G) and CD8+ (H) T cells in lung tissue from the 
indicated strains was quantified day 8 after RSV 
infection or after administration of PBS, as indi-
cated. (I) RSV-specific CD8+ T cells were detected 
using M187–195 tetramer staining on CD19, CD3+, 
and CD8+ lung cells. Both frequency and total 
cell numbers are shown. In A and B, the data are 
pooled from two independent experiments. In  
C–I, the results are presented as mean ± SEM of 
five mice per group, and the data represent one 
of at least two independent experiments. In A 
and C–I, statistical significance of differences 
between WT or Mavs/ mice at each time point 
was determined by unpaired Student’s t test.  
In B, statistically significant differences between 
uninfected mice and infected WT mice are repre-
sented by “#” and between RSV-infected WT 
mice and Mavs/ mice by “*.” Statistical differ-
ences between groups were determined by two-
way ANOVA with Bonferroni’s post hoc test.  
#,*, P < 0.05; ##,**, P < 0.01; ***, P < 0.001; ns, 
not significant; ND, not detectable.
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with AM transfer did not reach the level observed in control-
infected WT mice, it was nevertheless sufficient to partially 
restore accumulation of CD64hi inflammatory cells (Fig. 7, 
E and F) and lead to increased expression of TNF (Fig. 7 G).
In a second approach, Mavs/ mice were given a single 
administration of recombinant (r) IFN- i.n. 6 h p.i. to mimic 
type I IFN secretion by AMs in WT mice. This was sufficient 
to induce expression of Ccl2 (Fig. 8 A) and to partially restore 
recruitment of CD64hi inflammatory cells (Fig. 8, B and C) 
and lung TNF levels (Fig. 8 D). Finally, in a third approach, 
we bypassed type I IFNs entirely and directly administered 
rCCL2 to the airways of Mavs/ mice. After one dose of 
rCCL2 given 6 h p.i., CD64hi inflammatory cells were attracted 
secrete CCL2 (Fig. 7 C) or recruit CD64hi infMos to the lung 
after RSV infection (not depicted). We therefore hypothe-
sized that the absence of CD64hi inflammatory cell accumula-
tion in the lungs of RSV-infected Mavs/ mice and lack of 
local TNF production is caused by impaired monocyte re-
cruitment through failure of AMs to produce type I IFNs 
and consequent lack of local induction of monocyte chemo-
attractants. To test this hypothesis, we first transferred WT 
AMs i.n. into Mavs/ mice 24 h before RSV infection. This 
transfer led to an increase in CCL2 mRNA (48 h p.i.) in the 
lungs of Mavs/ mice that had been reconstituted with WT 
AMs as compared with Mavs/ mice that received Mavs/ 
AMs (Fig. 7 D). Although the induction of CCL2 achieved 
Figure . MAVS-dependent recruitment of TNF-producing CD6hi inflammatory cells to RSV-infected lungs. (A) Representative plots of 
CD11bhiCD64hi inflammatory cells in the lungs of mock (PBS)- or RSV-infected WT or Mavs/ mice 18 h p.i. with RSV. (B) Quantification of CD64hi 
inflammatory cells in the lungs of WT and Mavs/ mice during infection. Data are mean ± SEM of four to five mice per group. (C) Representative 
plots of Ly6C and CD11c expression on CD64hiCD11bhi inflammatory cells (gated as in Fig. S1 A) at the indicated time points after RSV infection of WT 
mice. (D) Representative histograms of Ly6C expression on CD64hi inflammatory cells at the indicated time points p.i. of WT mice. (E) Quantification of 
the total number of CD64hi cells split into CD11chi (moDCs; black) or CD11clo (infMos; gray) at the indicated time points p.i. of WT mice. Data are mean ±  
SEM of five mice per group. (F) Number of TNF-positive CD64hiCD11chi moDCs in the lungs of WT or Mavs/ mice at the indicated time points p.i. 0 h 
represents mock (PBS)-infected mice. Expression was determined by intracellular staining for TNF and flow cytometry analysis. Data are mean ± SEM of 
five mice per group. (G) Ex vivo production of TNF secreted into culture supernatants by total lung cells and FACS-sorted CD64hiCD11chi moDCs iso-
lated from WT mice at 18 h p.i. Each point represents one individual experiment using cells pooled from 25–40 mice. In A–F, the data are representa-
tive of at least two independent experiments. Statistical significance of differences between WT and Mavs/ mice at different time points was 
determined by unpaired Student’s t test. **, P < 0.01; ***, P < 0.001.
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mice (Fig. 10 A). Viral load was also decreased as assessed by 
the measurement of L and N gene copies at days 2 (40–55% 
reduction in RSV N and L gene copies) and 4 p.i. (45–75% 
reduction in RSV N and L gene copies; Fig. 10 B). This is 
likely a large underestimate of the antiviral effect of CCL2 
treatment because some of the antiviral effects of type I IFNs 
manifest themselves at points in the viral life cycle other than 
generation of viral RNA (such as, for example, viral packag-
ing and budding [Goubau et al., 2013]). Indeed, when actual 
viral titers were measured (by an immunoplaque assay), lungs 
of Mavs/ mice contained 100-fold higher virus levels at 
day 4 p.i. than controls, and this was nearly completely nor-
malized by CCL2 treatment (Fig. 10 C). We conclude that the 
type I IFN–dependent influx of CD64hi inflammatory cells 
into the lungs of RSV-infected mice is both necessary and 
sufficient to limit RSV replication and diminish disease se-
verity. Indeed, it accounts for most of the resistance to RSV 
infection conferred by MAVS.
DISCUSSION
Type I IFNs can be produced by many cell types in response 
to virus encounter. They act through the IFNAR to induce 
a large number of genes encoding inhibitors of viral replica-
tion and virus assembly that together mediate cell-intrinsic 
resistance to virus infection and protect from viral spread. 
Genetic association studies have implicated a role for the 
type I IFN system in severe lung inflammation induced by 
RSV infection in some individuals. However, the cellular 
origin of those type I IFNs and the physiological role of type I 
IFN–induced inflammation remains unclear. Here, we show 
that AMs are responsible for production of type I IFNs 
during lower respiratory tract RSV infection and use the 
RLR–MAVS pathway for RSV detection. Notably, loss 
of type I IFN production by AMs results in increased viral 
to the lungs (Fig. 8, E and F), and local production of TNF 
was restored (Fig. 8 G). NK cells were not recruited to lungs 
of the Mavs/ mice with or without administration of rCCL2, 
acting as a control for specificity (Fig. 8 H). Together, these 
data indicate that AMs promote the recruitment of CD64hi 
inflammatory cells to the lungs of RSV-infected mice through 
production of type I IFNs, which results in local induction of 
CCL2 and other monocyte chemoattractants and recruits 
CCR2+ monocytes.
CD6hi inflammatory cells limit viral  
replication and disease severity
To address the role of the recruited CD64hi inflammatory cells, 
we evaluated their contribution to disease severity, as mea-
sured by weight loss. As noted earlier, RSV-infected Mavs/ 
mice showed greater weight loss than controls (Figs. 4 B and 
9 A). Notably, this was completely prevented by prior transfer 
of WT but not Mavs/ AMs (Fig. 9 A). Weight loss in mice 
correlates with increased viral load (Pribul et al., 2008). In-
deed, RSV viral load was significantly lower in Mavs/ mice 
that received WT AMs compared with Mavs/ mice that 
were given Mavs/ AMs (70–85% reduction of RSV N and 
L gene copies; Fig. 9 B). As the transfer of WT AMs into 
Mavs/ mice results in type I IFN production, which can 
have pleiotropic and direct antiviral effects, we also used a 
depletion approach and found that viral load was increased 
in anti-CCR2–treated monocyte-depleted C57BL/6 mice 
despite normal production of type I IFNs (67–70% increase in 
RSV L and N gene copies; Fig. 9 C).
Finally, we administered rCCL2 to Mavs/ mice to ex-
amine the ability of CD64hi inflammatory cells to control 
disease in a setting that does not impact type I IFN induction. 
Remarkably, three doses of rCCL2 given during the course 
of infection almost completely prevented weight loss in Mavs/ 
Figure 6. CD6hi inflammatory cells are derived 
from monocytes and account for local TNF produc-
tion. (A and B) Representative flow cytometry plots (A) 
and percentage and total number of CD11bhiCD64hi in-
flammatory cells in the lung (B) 48 h after RSV or mock 
(PBS) infection of C57BL/6 mice, pretreated with PBS, 
anti-CCR2, or IgG2b isotype–matched control antibody, 
as indicated. (C) Tnfa transcript levels in lung tissue from 
mice as in A and B determined by quantitative RT-PCR. In 
B and C, data are shown as mean ± SEM of 10 mice per 
group pooled from two independent experiments with  
5 mice in each. Statistical significance of differences  
between the RSV-infected groups was determined by 
unpaired Student’s t test. *, P < 0.05; ***, P < 0.001.
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mouse model of RSV infection, we found that the major 
source of type I IFN is in fact AMs. AMs have a crucial role 
in maintaining lung homeostasis and clearing airway debris 
(Hussell and Bell, 2014). Their strategic positioning at the 
air–liquid interface also places them at key sites of respiratory 
virus entry. Indeed, AMs have been shown to produce type I 
IFN after Newcastle disease virus and influenza A virus infec-
tion (Kumagai et al., 2007; Helft et al., 2012). Our data add 
to the notion that AMs are part of a rapid innate first line of 
defense against invading lung pathogens.
We found that the ability of AMs to rapidly respond to 
RSV depends on the adaptor protein MAVS, consistent with 
studies suggesting that RSV can be recognized through both 
RIG-I and MDA5 (Liu et al., 2007; Bhoj et al., 2008; Loo 
et al., 2008; Yoboua et al., 2010; Demoor et al., 2012). This 
also suggests that AMs are directly exposed to infectious virus 
in vivo as engagement of the RLR pathway requires viral 
RNA presence in the cytosol. Interestingly, RSV has been 
shown to infect AMs ex vivo, but infection does not result 
in production of infectious viral particles (Ravi et al., 2013). 
This suggests that AMs are naturally resistant to RSV replication, 
replication and exacerbated disease. However, this is not fully 
attributable to loss of cell-intrinsic viral control but, rather, is 
associated with lack of recruitment of monocyte-derived in-
flammatory cells. We further show that these inflammatory 
cells are both necessary and sufficient to mediate type I IFN–
dependent control of RSV infection and to control RSV-
induced pathology. Thus, our data reveal an underappreciated 
facet of type I IFN–dependent resistance to viral infection 
that operates in a cell-extrinsic fashion through rapid recruit-
ment of antiviral infMos to sites of infection. They further 
suggest that type I IFN–dependent lung inflammation is a 
normal and important component of the antiviral response 
to RSV that, if dysregulated, might lead to severe disease 
in humans.
Most cells can produce type I IFNs, and epithelial cells, 
macrophages, fibroblasts, and pDCs have all been suggested 
as possible sources of these cytokines in response to RSV 
challenge (Jewell et al., 2007; Bhoj et al., 2008; Demoor 
et al., 2012). Most of those conclusions were based on studies 
involving in vitro exposure of cells to the virus, which may 
or may not reproduce virus accessibility in vivo. Using a 
Figure . Transfer of WT AMs into Mavs/ 
mice partially restores the recruitment of 
CD6hi inflammatory cells upon RSV infec-
tion. (A) Expression of Ccl7 and Ccl12 in lung 
tissue of RSV- or mock (PBS)-infected (0 h) mice 
of the indicated strains as measured by quantita-
tive RT-PCR. (B and C) Levels of CCL2 in lung 
homogenates from WT and Mavs/ mice (B) and 
in BAL of C57BL/6 and Ifnar1/ mice (C) were 
determined by ELISA. (D) Expression of Ccl2 deter-
mined by quantitative RT-PCR in lung tissue of 
the indicated mouse strains 48 h after mock (PBS; 
stated as naive) or RSV infection. Mice received or 
not AMs of the indicated genotype i.n. 24 h be-
fore challenge. (E) Representative flow cytometry 
plots for CD11bhiCD64hi inflammatory cells in the 
lung 48 h after i.n. RSV or mock infection of WT, 
Mavs/, or Mavs/ mice given WT AMs or 
Mavs/ AMs i.n. 24 h before infection as indi-
cated. (F) Percentage and number of CD64hi in-
flammatory cells in the lungs of mice treated as 
in D and E. (G) Expression of Tnfa determined by 
quantitative RT-PCR in the lungs of mice treated 
as in D and E. In A–C, data are mean ± SEM of 
four to five mice per group and are representa-
tive of two independent experiments. In D, F, and G, 
data are pooled from two independent experi-
ments with 5 mice per group and are depicted as 
mean ± SEM of 10 mice. Statistical significance 
of differences between WT and Mavs/ mice in 
A–C at each time point was determined by un-
paired Student’s t test. In D, F, and G, statistical 
differences between groups as indicated were 
determined by one-way ANOVA with Tukey’s post 
hoc test. *, P < 0.05; **, P < 0.01; ***, P < 0.001; 
ns, not significant.
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with that notion and previous data (Haeberle et al., 2001; 
Miller et al., 2004; Culley et al., 2006), we noticed that there 
is robust induction of CCL2, CCL7, and CCL12 in the lungs 
and recruitment of monocyte-derived cells early after RSV in-
fection. This was not observed in Mavs/ mice, but it was 
not a direct consequence of impaired RLR signaling in AMs. 
Rather, CCL2 production in several infection models is 
strongly dependent on type I IFN (Crane et al., 2009; Seo 
et al., 2011; Majer et al., 2012; Conrady et al., 2013), and we 
showed that the lack of type I IFN underlies the loss of CCL2. 
The cellular source of CCL2 during RSV infection in vivo is 
not known. A radioresistant cell type has been implicated in 
CCL2 production during HSV-1 infection of the cornea 
which may allow them to maintain sentinel activity while es-
caping the cytopathic effects of infection. Abortive viral rep-
lication may also render AMs less susceptible to the effect of 
the viral NS protein, which inhibits RLR activity (Spann 
et al., 2004; Ling et al., 2009; Boyapalle et al., 2012). NS 
protein–dependent blockade of the type I IFN responses 
could explain why lung epithelial cells do not register in our 
assays as a major source of type I IFN despite being the preva-
lent target of RSV infection and replication.
Local neutrophil and monocyte recruitment is a hallmark 
of inflammation. It occurs in response to chemokine produc-
tion induced by inflammatory cytokines or by signals from 
receptors that detect infection or tissue injury. Consistent 
Figure . Recombinant IFN- or CCL restores 
CD6hi inflammatory cell recruitment in Mavs/ 
mice after RSV infection. (A) Lung expression of 
Ccl2 determined by quantitative RT-PCR 48 h after 
mock (PBS) or RSV infection of WT or Mavs/ mice 
that received PBS or rIFN- i.n. 6 h after RSV infection, 
as indicated. (B and C) Representative flow cytometry 
plots (B) and quantification of CD11bhiCD64hi inflam-
matory cells (C) in mice as in A. (D) Expression of Tnfa 
in mice as in A. (E) Representative flow cytometry 
plots of CD11bhiCD64hi inflammatory cells in the lung 
of mock (PBS)- or RSV-infected WT, Mavs/, or 
Mavs/ mice receiving PBS or rCCL2 at 6 h after RSV 
infection. Mice were analyzed 48 h p.i. (F) Quantifica-
tion of CD64hiCD11bhi inflammatory cells in the lungs 
of mice as in E. (G) Expression of Tnfa in in the lungs 
of mice as in E. (H) Percentage of NK cells (CD3, 
NKp46+) in lungs of the indicated groups of mice.  
In A, D, and H, data are mean ± SEM of five mice per 
group and are representative of two independent 
experiments. In C, F, and G, data are pooled from two 
independent experiments with 5 mice per group and 
are depicted as mean ± SEM of 10 mice. Statistical 
significance of differences between indicated groups 
was determined by one-way ANOVA with Tukey’s 
post hoc test. *, P < 0.05; **, P < 0.01; ***, P < 0.001.
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The type I IFN–inducible monocyte chemoattractants 
mediate recruitment of monocyte-derived CD64hi inflamma-
tory cells, which make up as much as 40% of total lung leuko-
cytes at day 2 after RSV infection and can be identified by 
high expression of CD11b and CD64. The latter has been ar-
gued to be a better marker than Ly6C for detection of mono-
cyte progeny in the lung (Plantinga et al., 2013). Indeed, we 
found that Ly6C expression was down-regulated during the 
course of infection, especially from days 3 to 4 p.i. onwards. 
The CD64hi inflammatory cells can be subdivided into 
CD11clo and CD11chi cells, representing infMos and moDCs, 
respectively (Shi and Pamer, 2011; Segura et al., 2013). In-
terestingly, CD11c expression on the CD64hi inflammatory 
cells increased during infection, and almost all CD64hi cells 
were positive for CD11c after day 2 of infection. CD11c up- 
regulation has been interpreted as a sign of infMo conversion 
into moDCs, also known as Tip-DCs or inflammatory DCs 
(Conrady et al., 2013), and ex vivo infection using RSV elic-
ited CCL2 production from both AMs and primary airway 
epithelial cells (Demoor et al., 2012). A possible source of 
CCL2 may be AMs themselves responding to their own type I 
IFN production through signaling via IFNAR, consistent 
with the notion that macrophages can be a source of mono-
cyte chemoattractants (Deshmane et al., 2009).
Figure . Availability of CD6hi inflammatory cells correlates with 
outcome of RSV infection. (A) Percentage of original weight after RSV 
or mock (PBS) infection of the indicated strains, receiving or not WT AMs 
or Mavs/ AMs 24 h before challenge (day 0). (B) Lung viral load in the 
indicated strains, receiving or not WT AMs or Mavs/ AMs 24 h before 
RSV infection, was determined 48 h p.i. by quantitation of RSV L and N 
gene copies in lung tissue. Naive represents mock (PBS)-infected control 
mice. (C) Lung viral load in mock (PBS)- or RSV-infected C57BL/6 mice 
pretreated with isotype-matched control or anti-CCR2 antibody was de-
termined 48 h p.i. by quantitation of RSV L and N gene copies in lung 
tissue. In A, data are mean ± SEM of five mice per group and are repre-
sentative of two independent experiments. In B and C, data are pooled 
from two independent experiments with 5 mice per group and are de-
picted as mean ± SEM of 10 mice. In A, statistical significance of differ-
ences between Mavs/ mice receiving WT AMs and Mavs/ AMs was 
determined by two-way ANOVA with Bonferroni’s post hoc test. In B and C, 
statistical significance between the indicated groups was determined by 
one-way ANOVA with Tukey’s post hoc test in B and by unpaired Stu-
dent’s t test in C. *, P < 0.05; **, P < 0.01; ***, P < 0.001.
Figure 0. CD6hi inflammatory cells are sufficient to control RSV 
infection. (A) Percentage of original weight in mock (PBS)- or RSV-infected 
WT or Mavs/ mice with or without i.n. instillation of rCCL2 or PBS (as 
indicated) at 6, 18, and 48 h p.i. Day 0 indicates day of challenge. (B) Viral 
load in the indicated groups of mice (as in A) was determined by quantita-
tion of RSV L and N gene copies in lung tissue at days 2 and 4 p.i. (C) Enu-
meration of infectious particles in lung tissue of the indicated groups of 
mice (see A) using an immunoplaque assay on day 4 p.i. Results in A–C are 
presented as mean ± SEM of five mice per group and are representative of 
two independent experiments. In A, statistical significance of differences 
between Mavs/ mice receiving CCL2 and PBS was determined by two-
way ANOVA with Bonferroni’s post hoc test. Statistical significance between 
the indicated groups in B and C was determined by one-way ANOVA with 
Tukey’s post hoc test. *, P < 0.05; **, P < 0.01; ***, P < 0.001.
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Notably, the fact they are recruited and persist in the lung 
long after the production of type I IFNs has waned serves in 
part to temporally extend the antiviral effect of the cytokines 
and explains how the effects of the latter can manifest many 
days into the infection course.
IFNAR1- or MAVS-deficient mice infected with RSV 
ultimately recover and clear the virus, consistent with a key 
role for adaptive immune mechanisms in protection from the 
virus. Nevertheless, Mavs/ mice lose more weight and dis-
play greater lung viral titers than control mice during RSV 
infection, implicating a cost in morbidity. Supporting this 
notion, viral titers in nasal washes from children with bronchi-
olitis have been shown to correlate positively with severity 
and duration of hospital stay (El Saleeby and Devincenzo, 
2011; Scagnolari et al., 2012). We therefore propose that 
monocyte recruitment via the type I IFN–CCL2 axis is a 
natural component of the early inflammatory response to 
RSV infection, designed to keep the virus under control 
until lymphocyte-dependent protection takes over. However, 
monocyte-derived inflammatory cells can also induce tissue 
damage. For example, type I IFN– and CCL2-driven mono-
cytosis induces lethal kidney pathology during experimental 
systemic infection with Candida albicans (Majer et al., 2012). 
Furthermore, infMos contribute to lung pathology in a model 
of influenza virus infection (Herold et al., 2008; Lin et al., 
2008; Davidson et al., 2014), and CCL2 is increased in nasal 
secretions or BAL of children with RSV bronchiolitis (Garofalo 
et al., 2001; Welliver et al., 2002; McNamara et al., 2005). 
Lungs are particularly delicate, and unbridled inflammation at 
those sites can block gas exchange, with disastrous conse-
quences for the host. Therefore, the production of type I IFNs 
and recruitment of antiviral monocytes during RSV infection 
must be carefully balanced to reduce viral load but not allow 
excessive cell infiltration. It is interesting to speculate that ge-
netically or environmentally driven alterations to this balance 
possibly underlie the susceptibility of some human patients to 
RSV-induced bronchiolitis and pneumonia.
MATERIALS AND METHODS
Mice. C57BL/6 mice were purchased from Charles River or Harlan Labo-
ratories, Inc. Ifnar1/ mice on a C56BL/6 background were obtained from 
C. Reis e Sousa (London Research Institute, London, England, UK). Ifna6gfp 
transgenic mice and Ifna6gfp mice deficient in MAVS (Mavs/; Kumagai 
et al., 2007) were used as heterozygotes (Ifna6gfp/+). For all experiments in 
which GFP is not a primary readout (Fig. 4 onwards), the Ifna6gfp/+ mice are 
designated as WT mice and Ifna6gfp/+ Mavs/ as Mavs/ mice for simplicity 
and to denote the fact that the mice may or may not have a copy of the gfp 
insert at the Ifna6 locus. In all experiments with genetically modified mice 
(e.g., Mavs/ mice), littermates were always used as the control groups 
(e.g., WT mice). All mice were bred and maintained in pathogen-free con-
ditions, and gender- and age-matched mice aged 7–12 wk were used for 
each experiment. All animal experiments were reviewed and approved by 
the Animal Welfare and Ethical Review Board (AWERB) within Imperial 
College London and approved by the UK Home Office in accordance with 
the Animals (Scientific Procedures) Act 1986 and the ARRIVE guidelines.
Virus and infections. Plaque-purified human RSV (originally A2 strain 
from the ATCC) was grown in HEp-2 cells (Lee et al., 2010). Inactivation 
was performed by exposing virus to UV light for 2 min in a CX-2000 UV 
(Shi and Pamer, 2011; Segura et al., 2013). moDCs might 
play a role in local antigen acquisition, antigen presentation, 
and/or antigen transport to lymph nodes or restimulation of 
T cells in infected tissues, as suggested in other infection models 
(Serbina and Pamer, 2006; Iijima et al., 2011; Plantinga et al., 
2013; Samstein et al., 2013). However, we did not detect 
impaired T cell responses in Mavs/ mice compared with 
WT mice. Therefore, we focused on the function of recruited 
CD64hi inflammatory cells in the early T cell–independent 
response to RSV. Interestingly, we observed that CD64hi in-
flammatory cells play a major role in restricting virus production 
and dampening disease severity. Similarly, monocyte-derived 
cells have recently been shown to limit HSV-2 and HSV-1 
replication in the vaginal tract and in the cornea, respectively 
(Iijima et al., 2011; Conrady et al., 2013).
The nature of the antiviral mechanism, whether it resides 
within the CD11chi or CD11clo population and how it limits 
disease severity remains unclear. It is possible that the antivi-
ral activity is mediated in part by the production of TNF 
and/or inducible nitric oxide synthase (iNOS), consistent 
with the original function ascribed to Tip-DCs (Serbina 
et al., 2003). Increased RSV load has been observed in mice 
treated with anti-TNF (Rutigliano and Graham, 2004), and 
TNF can limit RSV replication in human lung epithelial cells 
(Merolla et al., 1995). Consistent with this notion, CD64hi 
inflammatory cells in our model produced TNF and their 
absence led to a major loss of TNF in total lung extracts. Ni-
tric oxide has also been implicated in monocyte-dependent 
antiviral control in a model of HSV-1 infection of the eye 
(Conrady et al., 2013). However, we failed to see an effect of 
iNOS inhibition on RSV lung titers in C57BL/6 mice (un-
published data) even though a study in BALB/c mice re-
ported that it could increase infection (Stark et al., 2005). 
Another possibility could be that CD64hi inflammatory cells 
express TNF-related apoptosis-inducing ligand (TRAIL) and 
kill RSV-infected epithelial cells, as reported for influenza 
virus infection (Herold et al., 2008; Davidson et al., 2014). 
However, we did not detect TRAIL expression on CD64hi 
inflammatory cells during RSV infection (unpublished data). 
As for the impact of CD64hi inflammatory cells on disease 
severity, it likely simply reflects their ability to control viral 
spread and thereby diminish the cytopathic effects of infec-
tion. However, CD64hi inflammatory cells could also help 
promote epithelial cell repair via the secretion of trophic or 
antiinflammatory factors such as, for example, hepatocyte 
growth factor (Narasaraju et al., 2010) or prostaglandin E2 
(Grainger et al., 2013). In this regard, it is interesting to note 
that CCL2 inhibition during influenza A virus infection can 
exacerbate epithelial damage (Narasaraju et al., 2010). We 
did not find prostaglandin production by CD64hi inflamma-
tory cells after RSV infection (unpublished data). Thus, the 
mechanism by which CD64hi inflammatory cells mediate their 
antiviral effect and protect from disease remains elusive at 
present and is possibly multifactorial. Nevertheless, these cells 
are clearly a key component of resistance to the virus and 
constitute a cell-extrinsic mechanism of action of type I IFNs. 
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from the National Institutes of Health Tetramer Core Facility, Emory Univer-
sity, Atlanta, GA) for 30 min in the dark at room temperature. Surface stain-
ing was then performed using CD3 (145-2C11, PE-Cy7), CD4 (GK1.5, 
APC-H7), CD8 (53-6.7, AF700), and CD19 (1D3, FITC). Cells were fixed 
for 30 min in BD Cytofix/Cytoperm fixation buffer at 4°C, washed, and 
analyzed on a BD LSRFortessa equipped with 50-mW 405-nm, 50-mW 
488-nm, 50-mW 561-nm, 20-mW 633-nm lasers and an ND1.0 filter in 
front of the FSC photodiode. Acquisition was set to 250,000 live, single 
cells. For intracellular staining for TNF, surface-stained and fixed cells (as 
described above) were stained with fluorochrome-conjugated anti-TNF 
(MP6-XT22, BV650) in the presence of purified rat IgG2b anti–mouse 
CD16/CD32 receptor in BD permeabilization buffer for 60 min at 4°C. 
Samples were analyzed on a BD LSRFortessa-SORP equipped with 20-mW 
355-nm, 50-mW 405-nm, 50-mW 488-nm, 50-mW 561-nm, 20-mW 
633-nm lasers and an ND1.0 filter in front of the FSC photodiode. Acquisi-
tion was set to 250,000 live, single cells. All antibodies were purchased from 
BD, BioLegend, or eBioscience. Data were analyzed with FlowJo software 
(Tree Star).
FACS. For CD45/+ lung cell sorting, cells were, after dispase digestion of 
the lung tissue, stained as described above. For leukocyte cell sorting, lung 
single cell suspensions were incubated for 20 min with a purified rat IgG2b 
anti–mouse CD16/CD32 receptor antibody, after which CD11c enrich-
ment was performed by incubating the lung cells with anti-CD11c micro-
beads (N418; Miltenyi Biotec) for 15 min on a shaker and positive selection 
on an autoMACS Pro Separator (Miltenyi Biotech). In some cases, the nega-
tive fraction was further processed to enrich for CD11cint pDCs using anti-
PDCA1 microbeads (Miltenyi Biotech). The positively selected cell fractions 
were stained as described above. Cells were then sorted using a standard BD 
Aria III equipped with 50-mW 405-nm, 50-mW 488-nm, 50-mW 561-nm, 
20-mW 633-nm lasers and an ND1.5 filter in front of the FSC photodiode, 
a nozzle size of 100 µm, and corresponding BD FACSFlow sheath pressure 
of 20 psi, matched with a transducer frequency of 29 kHz. Input pressure 
was adjusted to ensure that every fifth to sixth drop was populated by an 
event. FACS-sorted cells were cultured overnight (see below) or stored in 
TRIzol until RNA extraction was performed.
RNA isolation and quantitative RT-PCR. Total RNA was isolated 
from homogenized lung tissue using an RNeasy Mini kit (QIAGEN) ac-
cording to the manufacturer’s instructions. RNA extraction from sorted cells 
was performed using TRIzol (Invitrogen) according to the manufacturer’s 
instructions. After the chloroform step, the aqueous phase–containing RNA 
was further processed using the RNeasy Micro kit (QIAGEN) according to 
the manufacturer’s instructions. 1 µg RNA (total lung) or 9 µl (FACS-sorted 
cells) was reverse transcribed using a High Capacity RNA-to-cDNA kit 
(Applied Biosystems) according to the manufacturer’s instructions. To quan-
tify mRNA levels in lung tissue, quantitative RT-PCR reactions for Ifnl2/3, 
Ifnb, Tnfa, Ifng, Eif2ak2, Oas1a, Rsad2, and RSV L and N gene were per-
formed using primers and probes as previously described (Culley et al., 2002; 
Perkins et al., 2005; Lee et al., 2010; Slater et al., 2010; Bartlett et al., 2012; 
Goritzka et al., 2014). Analysis was performed using the QuantiTect Probe 
PCR Master Mix (QIAGEN) and the 7500 Fast Real-Time PCR System 
(Applied Biosystems). For absolute quantification, the exact number of cop-
ies of the gene of interest was calculated using a plasmid DNA standard 
curve, and the results were normalized to levels of Gapdh, a housekeeping 
gene (Applied Biosystems). For relative quantification, the expression of 
Ifna5, Mx1, Ccl2, Cxcl1, Ccl7, Ccl12, Il6, and Il1b (all from Applied Biosys-
tems) was expressed relatively to the expression of Gapdh. First, the Ct (Ct = 
cycle threshold) between the target gene and Gapdh for each sample was cal-
culated, after the calculation of 2Ct. Analysis was performed using 7500 
Fast System SDS Software (Applied Biosystems).
Chemokine and cytokine detection. Lungs were placed in protease in-
hibitor cocktail (Roche) on ice and homogenized using a TissueLyser (QIA-
GEN). Homogenate was centrifuged for 10 min, 10,000 g at 4°C, and 
chemokine and cytokine quantification was then performed on the supernatant. 
cross-linker (UVP). For infection, mice were lightly anesthetized and in-
stilled i.n. with 1.5–2 × 106 FFU of RSV in 100 µl. In some instances, this 
was followed by i.n. instillation of recombinant proteins (500 ng/mouse 
IFN-11 [Miltenyi Biotech] and 25 µg/mouse rCCL2 [PeproTech]) at 6 h 
p.i. For experiments monitoring the effect of CCL2 on weight loss and viral 
load day 4 p.i., rCCL2 (25 µg/mouse) was additionally given i.n. at 18 and 
48 h p.i. For monocyte depletion, the anti-CCR2 antibody MC21 or an 
IgG2b isotype-matched control of irrelevant specificity (BD) was adminis-
tered i.p. at 20 µg/mouse 6 h before and then daily during infection (Mack 
et al., 2001). For AM transfer into MAVS-deficient mice, 4–5 × 105 AMs 
pooled from 10 WT or Mavs/ mice were administered via the i.n. route 
in 100 µl PBS 24 h before infection. RSV titer was assessed in fresh lungs 
4 d after RSV infection using an immunoplaque assay (optimized from 
Loebbermann et al. [2012]). In brief, lung homogenate was titrated on HEp-2 
cell monolayers in 96-well, flat-bottom plates and incubated for 2 h on a 
shaker. Then, pyruvate-free DMEM containing 2% FCS was added and the 
plate was further incubated for 20 h before being fixed with methanol and 
incubated with biotin-conjugated goat anti-RSV antibody (Biogenesis). 
Infected cells were detected using Streptavidin (Sigma-Aldrich) and DAB 
substrate (diaminobenzidine tetrahydrochloride), enumerated by light micros-
copy and used to calculate titer as FFU.
Isolation of lung cells. Mice were sacrificed at different times p.i. and per-
fused with PBS. To obtain lung leukocytes, lung lobes were collected into a 
C-Tube (Miltenyi Biotech) containing complete DMEM (cDMEM; sup-
plemented with 10% fetal bovine serum, 2 mM l-glutamine, 100 U/ml 
penicillin, and 100 µg/ml streptomycin), 1 mg/ml Collagenase D (Roche) 
and 30 µg/ml DNase I (Invitrogen) and processed with a gentleMACS dis-
sociator (Miltenyi Biotech) according to the manufacturer’s protocol. Shred-
ded tissue was incubated for 1 h at 37°C. After lysis of red blood cells, cells 
were strained through a 100-µm filter (BD). To obtain epithelial and endo-
thelial cells, perfused lungs were injected and digested with 5 mg/ml Dispase 
(Roche) and 250 µg/ml DNase I (Sigma-Aldrich), as reported previously 
(Messier et al., 2012). Primary AMs for ex vivo stimulations and adoptive 
transfer were collected by BAL by flushing the lungs three times with 1 ml 
PBS supplemented with 5 mM EDTA (Life Technologies). The lavage was 
repeated twice, and AMs from several mice were pooled. The purity of AMs 
was >98% assessed by flow cytometry.
BAL cell processing. To determine the cellular composition of the BAL, 
cells were transferred onto a microscope slide (Thermo Fisher Scientific) 
using a Shandon Cytospin 3 centrifuge, and slides were stained with hema-
toxylin and eosin (H&E; Reagena, Gamidor). Cells were categorized as mac-
rophages, lymphocytes, neutrophils, and eosinophils based on morphology 
and size under a light microscope (Axio; Carl Zeiss; Durant et al., 2014).
Flow cytometry. For staining, cells were first incubated for 30 min with 
fixable live-dead Aqua dye (Invitrogen), followed by incubation for 20 min 
with a purified rat IgG2b anti–mouse CD16/CD32 receptor antibody (BD) 
to block Fc binding. Cells were then stained with fluorochrome-conjugated 
antibodies against CD11c (HL3, PE-CF594), CD11b (M1/70, AF700), CD45 
(30-F11, eFluor780), Ly6C (HK1.4, eFluor450), CD103 (2E7, PerCP-Cy5.5), 
Siglec-H (eBio440c, eFluor660), B220 (RA3-6B2, eFluor450), Siglec-F 
(E50-2450, PE), CD64 (X54-5/7.1, APC), Ly6G (1A8, BV570), NKp46 
(29A1.4, eFluor450), EpCAM (G8.8, PerCP-Cy5.5), and/or CD31 
(MEC13.3, PE) in PBS containing 1% BSA, 5 mM EDTA, and 0.05% NaN3 
for 25 min at 4°C. The samples were analyzed without fixation on a stan-
dard BD LSRII equipped with 50-mW 405-nm, 50-mW 488-nm, 20-mW 
633-nm lasers and an ND1.0 filter in front of the FSC photodiode. Ac-
quisition was set to 500,000 live, single cells when pDC staining was in-
cluded; otherwise, 250,000 live, single cells were acquired. For tetramer 
staining, cells were, after incubation with fixable live-dead Aqua dye (Invit-
rogen) and anti–mouse CD16/CD32 receptor antibody, stained with Alexa 
Fluor 647–conjugated M187–195 tetramers (H-2Db/NAITNAKII; obtained 
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 Figure S1.  Gating strategy for identifying and sorting lung cell populations. Mice were infected with RSV. (A) At 18 h p.i., lung cells were obtained 
by collagenase digestion and stained for the indicated cell surface molecules. After excluding debris and gating on singlet live CD45 + cells, the depicted 
gates were used to identify neutrophils, eosinophils, AMs, conventional DCs (cDCs), pDCs, moDCs, and infMos. (B) Lung cells were obtained by dispase 
digestion and stained for the indicated surface molecules. After excluding debris and gating on singlet live cells, the depicted gates were used to identify 
CD45 + cells and CD45    epithelial and endothelial cells. 
